Preface | p. xi |
Contributors | p. xiii |
Acknowledgements | p. xvii |
The Reproductive Biology and Spawning of Zebrafish in Laboratory Settings | p. 1 |
Introduction | p. 1 |
Overview of Zebrafish Reproductive Biology and Behavior | p. 2 |
Spawning Techniques and Technology | p. 5 |
Determining Factors for Reproduction in Laboratory Stocks of Zebrafish | p. 8 |
Conclusions | p. 11 |
References | p. 11 |
Developmental Toxicity Assessment in Zebrafish | p. 15 |
Introduction | p. 15 |
Methods | p. 16 |
Results | p. 20 |
Discussion | p. 23 |
References | p. 25 |
Use of Emerging Models for Developmental Toxicity Testing | p. 27 |
Importance of Assessing Developmental Toxicity | p. 27 |
Current Methods for Assessing Developmental Toxicity | p. 27 |
Use of Emerging Models for Developmental Toxicity Testing | p. 28 |
New Guidelines for Chemical Testing Using Zebrafish | p. 29 |
References | p. 43 |
Assessment of Drug-Induced Cardiotoxicity in Zebrafish | p. 45 |
Introduction | p. 45 |
Zebrafish Heart | p. 45 |
Summary of Cardiotoxicity Study Design and Results | p. 47 |
Materials and Methods | p. 47 |
Results | p. 50 |
Conclusions | p. 54 |
References | p. 54 |
Cardiotoxicity Studies in Zebrafish | p. 55 |
Introduction | p. 55 |
Repolarization Toxicity | p. 56 |
Initial Screening: Bradycardia | p. 56 |
High-Resolution Assays of Repolarization | p. 59 |
Furture Directions | p. 61 |
References | p. 62 |
In Vivo Recording of the Adult Zebrafish Electrocardiogram | p. 65 |
Introduction | p. 65 |
Optimization of Zebrafish Electrocardiogram Recording | p. 66 |
Basic Intervas | p. 68 |
Drug Effects | p. 69 |
Conclusions | p. 71 |
References | p. 72 |
Hematopoietic and Vascular System Toxicity | p. 73 |
Introduction | p. 73 |
Hematopoiesis and Vascular Development in the Zebrafish | p. 73 |
Morphological and Functional Assays to Assess Toxicity | p. 77 |
Summary | p. 85 |
Acknowledgement | p. 85 |
References | p. 85 |
Hepatotoxicity Testing in Larval Zebrafish | p. 89 |
Introduction: The Larval Zebrafish Model | p. 89 |
Liver Development | p. 89 |
Hepatic Gene Knockdown and Mutation | p. 91 |
Hepatotoxicity Testing in Drug Discovery | p. 92 |
Phenotypic-Based Larval Zebrafish Hepatotoxicity Screens | p. 93 |
Secondary and Mechanistic Liver Assays | p. 96 |
Conclusions | p. 99 |
References | p. 99 |
Whole Zebrafish Cytochrome P450 Assay for Assessing Drug Metabolism and Safety | p. 103 |
Introduction | p. 103 |
Background and Significance | p. 104 |
Materials and Methods | p. 105 |
Results | p. 107 |
Conclusions | p. 113 |
Acknowledgement | p. 113 |
References | p. 113 |
Methods for Assessing Neurotoxicity in Zebrafish | p. 117 |
Introduction | p. 117 |
Limitations of Current Neurotoxicity Testing | p. 118 |
Assessing Neurotoxicity in Zebrafish | p. 118 |
Summary | p. 130 |
Acknowledgement | p. 131 |
References | p. 131 |
Zebrafish: A Predictive Model for Assessing Cancer Drug-Induced Organ Toxicity | p. 155 |
Introduction | p. 135 |
Materials and Methods | p. 136 |
Results | p. 139 |
Conclusions | p. 149 |
References | p. 149 |
Locomotion and Behavioral Toxicity in Laraval Zebrafish: Background, Methods, and Data | p. 151 |
Introduction | p. 151 |
Background | p. 152 |
Locomotion | p. 153 |
Zebrafish Models | p. 154 |
Analyzing Larval Locomotion | p. 155 |
Chemical Effects on Larval Locomotion | p. 158 |
Conclusions | p. 161 |
Acknowledgement | p. 162 |
References | p. 162 |
Zebrafish: A Predictive Model for Assessing Seizure Liability | p. 165 |
Introduction | p. 165 |
Materials and Methods | p. 167 |
Results | p. 171 |
Conclusions | p. 174 |
References | p. 175 |
Zebrafish: A New In Vivo Model for Identifying P-Glycoprotein Efflux Modulators | p. 177 |
Introduction | p. 177 |
Materials and Methods | p. 179 |
Results | p. 182 |
Conclusions | p. 188 |
Acknowledgments | p. 188 |
References | p. 189 |
Assessment of Effects on Visual Function in Larval Zebrafish | p. 191 |
Introduction | p. 191 |
Development of Visual System in Zebrafish | p. 192 |
Methods for Assessing Visual Function in Larval Zebrafish | p. 194 |
Conclusions | p. 202 |
References | p. 202 |
Development of a Hypoxia-Induced Zebrafish Choroidal Neovascularization Model | p. 205 |
Introduction | p. 205 |
Materials and Methods | p. 207 |
Results | p. 210 |
Discussion | p. 215 |
Acknowledgments | p. 217 |
References | p. 217 |
Zebrafish Xenotransplant Cancer Model for Drug Screening | p. 219 |
Introduction | p. 219 |
Background and Significance | p. 219 |
Materials and Methods | p. 221 |
Results | |
Conclusions | p. 230 |
References | p. 231 |
Zebrafish Assays for Identifying Potential Muscular Dystrophy Drug Candidates | p. 233 |
Introduction | p. 233 |
Materials and Methods | p. 238 |
Results | p. 242 |
Discussion | p. 251 |
Acknowledgment | p. 252 |
References | p. 252 |
Cytoprotective Activities of Water-Soluble Fullerenes in Zebrafish Models | p. 257 |
Introduction | p. 257 |
Materials and Methods | p. 261 |
Results | p. 265 |
Discussion | p. 277 |
Conclusions | p. 278 |
Acknowledgments | p. 278 |
References | p. 279 |
Fishing to Design Inherently Safer Nanoparticles | p. 283 |
Introduction | p. 283 |
Application of Embryonic Zebrafish | p. 284 |
Tier 1: Rapid Toxicity Screening | p. 286 |
Tier 2: Cellular Toxicity and Distribution | p. 288 |
Tier 3: Molecular Expression | p. 289 |
Embryonic Zebrafish Data to Design "Safer" Nanoparticles | p. 291 |
Conclusions | p. 292 |
References | p. 292 |
Radiation-Induced Toxicity and Radiation Response Modifiers in Zebrafish | p. 295 |
Introduction | p. 295 |
Materials and Methods | p. 296 |
Validation of Zebrafish Embryos as a Model System for Radiation Protectors/Sensitizers | p. 298 |
Gross Morphological Alterations Associated with Radiation Exposure | p. 299 |
Radiation-Associated Apoptosis Incidence | p. 299 |
Radiation-Associated Gastrointestinal Toxicity | p. 300 |
Radiation-Associated Nephrotoxicity | p. 301 |
Ototoxicity in Irradiated Zebrafish | p. 301 |
Radiation Protectors in Zebrafish | p. 302 |
Summary | p. 303 |
References | p. 304 |
Caudal Fin Regeneration in Zebrafish | p. 307 |
Introduction | p. 307 |
Signaling and Epimorphic Regeneration | p. 308 |
Caudal Fin Architecture | p. 308 |
Stages of Epimorphic Regeneration | p. 309 |
Methodology | p. 311 |
Strategies Used to Manipulate Gene Function During Fin Regeneration | p. 312 |
The Largal Fin Regeneration Model | p. 316 |
Summary | p. 317 |
Acknowledgement | p. 317 |
References | p. 317 |
Index | p. 321 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.